ArticleClinicoEconomics and outcomes research : CEOR2009

Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab.

Francesco Patti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.